Bridgewater Associates LP Reduces Stake in Encompass Health Co. (NYSE:EHC)

Bridgewater Associates LP lowered its position in Encompass Health Co. (NYSE:EHC) by 72.0% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 16,140 shares of the company’s stock after selling 41,537 shares during the period. Bridgewater Associates LP’s holdings in Encompass Health were worth $1,560,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other large investors have also recently bought and sold shares of EHC. UMB Bank n.a. boosted its position in Encompass Health by 387.7% in the third quarter. UMB Bank n.a. now owns 317 shares of the company’s stock valued at $31,000 after buying an additional 252 shares during the last quarter. V Square Quantitative Management LLC boosted its position in Encompass Health by 53.0% in the third quarter. V Square Quantitative Management LLC now owns 404 shares of the company’s stock valued at $39,000 after buying an additional 140 shares during the last quarter. Oakworth Capital Inc. acquired a new position in Encompass Health in the second quarter valued at approximately $40,000. Avior Wealth Management LLC acquired a new position in Encompass Health in the third quarter valued at approximately $40,000. Finally, Benjamin F. Edwards & Company Inc. lifted its holdings in Encompass Health by 58.9% in the second quarter. Benjamin F. Edwards & Company Inc. now owns 534 shares of the company’s stock valued at $46,000 after acquiring an additional 198 shares during the period. Hedge funds and other institutional investors own 97.25% of the company’s stock.

Encompass Health Stock Up 0.1 %

NYSE EHC opened at $102.94 on Monday. The business has a fifty day moving average price of $98.16 and a 200 day moving average price of $91.42. Encompass Health Co. has a one year low of $63.78 and a one year high of $104.55. The company has a debt-to-equity ratio of 0.88, a quick ratio of 1.04 and a current ratio of 1.04. The company has a market cap of $10.37 billion, a P/E ratio of 24.86, a P/E/G ratio of 1.36 and a beta of 0.88.

Encompass Health (NYSE:EHC) last posted its quarterly earnings data on Monday, October 28th. The company reported $1.03 EPS for the quarter, beating the consensus estimate of $0.94 by $0.09. Encompass Health had a return on equity of 17.60% and a net margin of 8.10%. The firm had revenue of $1.35 billion during the quarter, compared to the consensus estimate of $1.33 billion. During the same period in the prior year, the company earned $0.86 EPS. The firm’s revenue was up 11.9% compared to the same quarter last year. Research analysts anticipate that Encompass Health Co. will post 4.29 EPS for the current fiscal year.

Encompass Health Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Wednesday, January 15th. Shareholders of record on Thursday, January 2nd will be issued a $0.17 dividend. This represents a $0.68 annualized dividend and a yield of 0.66%. The ex-dividend date is Thursday, January 2nd. Encompass Health’s payout ratio is currently 16.43%.

Analysts Set New Price Targets

A number of research analysts have issued reports on EHC shares. Truist Financial reissued a “buy” rating and issued a $116.00 price target (up from $108.00) on shares of Encompass Health in a report on Wednesday, October 30th. Barclays boosted their price target on Encompass Health from $109.00 to $116.00 and gave the company an “overweight” rating in a report on Tuesday, October 29th. Stephens reaffirmed an “overweight” rating and set a $105.00 target price on shares of Encompass Health in a research note on Tuesday, August 6th. Royal Bank of Canada upped their target price on Encompass Health from $105.00 to $110.00 and gave the stock an “outperform” rating in a research note on Wednesday, October 30th. Finally, KeyCorp upped their target price on Encompass Health from $115.00 to $117.00 and gave the stock an “overweight” rating in a research note on Tuesday, October 29th. Nine investment analysts have rated the stock with a buy rating and two have issued a strong buy rating to the company. According to MarketBeat.com, the company has an average rating of “Buy” and an average price target of $107.11.

About Encompass Health

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.